- Home
- DAWN vs FSLR Comparison
DAWN vs FSLR Comparison
Compare DAWN & FSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- FSLR
- Stock Information
- Founded
- DAWN 2018
- FSLR 1999
- Country
- DAWN United States
- FSLR United States
- Employees
- DAWN N/A
- FSLR N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- FSLR Semiconductors
- Sector
- DAWN Health Care
- FSLR Technology
- Exchange
- DAWN Nasdaq
- FSLR Nasdaq
- Market Cap
- DAWN 658.9M
- FSLR 13.1B
- IPO Year
- DAWN 2021
- FSLR 2006
- Fundamental
- Price
- DAWN $6.63
- FSLR $177.06
- Analyst Decision
- DAWN Strong Buy
- FSLR Strong Buy
- Analyst Count
- DAWN 7
- FSLR 29
- Target Price
- DAWN $31.57
- FSLR $232.30
- AVG Volume (30 Days)
- DAWN 1.3M
- FSLR 5.4M
- Earning Date
- DAWN 07-29-2025
- FSLR 07-29-2025
- Dividend Yield
- DAWN N/A
- FSLR N/A
- EPS Growth
- DAWN N/A
- FSLR 23.43
- EPS
- DAWN N/A
- FSLR 11.77
- Revenue
- DAWN $161,922,000.00
- FSLR $4,256,749,000.00
- Revenue This Year
- DAWN $17.98
- FSLR $22.39
- Revenue Next Year
- DAWN $49.50
- FSLR $21.13
- P/E Ratio
- DAWN N/A
- FSLR $15.04
- Revenue Growth
- DAWN N/A
- FSLR 19.42
- 52 Week Low
- DAWN $6.08
- FSLR $116.56
- 52 Week High
- DAWN $16.76
- FSLR $262.72
- Technical
- Relative Strength Index (RSI)
- DAWN 49.20
- FSLR 60.13
- Support Level
- DAWN $6.22
- FSLR $158.81
- Resistance Level
- DAWN $6.95
- FSLR $189.50
- Average True Range (ATR)
- DAWN 0.25
- FSLR 8.80
- MACD
- DAWN 0.03
- FSLR 2.51
- Stochastic Oscillator
- DAWN 57.41
- FSLR 76.96
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.